nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP3A4—Everolimus—kidney cancer	0.0835	0.201	CbGbCtD
Rifabutin—CYP1A2—Pazopanib—kidney cancer	0.0565	0.136	CbGbCtD
Rifabutin—CYP3A4—Temsirolimus—kidney cancer	0.0564	0.136	CbGbCtD
Rifabutin—CYP1A2—Erlotinib—kidney cancer	0.0404	0.0972	CbGbCtD
Rifabutin—CYP1A2—Sorafenib—kidney cancer	0.0328	0.0791	CbGbCtD
Rifabutin—CYP3A4—Pazopanib—kidney cancer	0.0296	0.0714	CbGbCtD
Rifabutin—CYP3A4—Erlotinib—kidney cancer	0.0211	0.0509	CbGbCtD
Rifabutin—CYP3A4—Paclitaxel—kidney cancer	0.0194	0.0466	CbGbCtD
Rifabutin—CYP3A4—Sorafenib—kidney cancer	0.0172	0.0414	CbGbCtD
Rifabutin—CYP3A4—Vinblastine—kidney cancer	0.017	0.0409	CbGbCtD
Rifabutin—CYP3A4—Vincristine—kidney cancer	0.0167	0.0402	CbGbCtD
Rifabutin—CYP3A4—Sunitinib—kidney cancer	0.0139	0.0336	CbGbCtD
Rifabutin—CYP3A4—Doxorubicin—kidney cancer	0.0104	0.0251	CbGbCtD
Rifabutin—HSP90B1—nephron tubule—kidney cancer	0.00756	0.0896	CbGeAlD
Rifabutin—HSP90B1—renal system—kidney cancer	0.00687	0.0814	CbGeAlD
Rifabutin—HSP90B1—kidney—kidney cancer	0.00665	0.0787	CbGeAlD
Rifabutin—CYP1A2—urine—kidney cancer	0.00664	0.0787	CbGeAlD
Rifabutin—HSP90B1—cortex of kidney—kidney cancer	0.00647	0.0767	CbGeAlD
Rifabutin—HSP90B1—gonad—kidney cancer	0.00617	0.073	CbGeAlD
Rifabutin—HSP90B1—cardiac atrium—kidney cancer	0.00616	0.0729	CbGeAlD
Rifabutin—HSP90AA1—nephron tubule—kidney cancer	0.00553	0.0655	CbGeAlD
Rifabutin—HSP90AA1—renal system—kidney cancer	0.00503	0.0595	CbGeAlD
Rifabutin—HSP90AA1—kidney—kidney cancer	0.00486	0.0576	CbGeAlD
Rifabutin—CYP3A4—urine—kidney cancer	0.00481	0.0569	CbGeAlD
Rifabutin—HSP90AA1—cortex of kidney—kidney cancer	0.00473	0.0561	CbGeAlD
Rifabutin—HSP90AA1—gonad—kidney cancer	0.00451	0.0534	CbGeAlD
Rifabutin—HSP90AA1—cardiac atrium—kidney cancer	0.0045	0.0533	CbGeAlD
Rifabutin—CYP1A2—renal system—kidney cancer	0.00163	0.0192	CbGeAlD
Rifabutin—CYP3A4—renal system—kidney cancer	0.00118	0.0139	CbGeAlD
Rifabutin—CYP3A4—kidney—kidney cancer	0.00114	0.0135	CbGeAlD
Rifabutin—Dyspepsia—Sorafenib—kidney cancer	0.00031	0.00105	CcSEcCtD
Rifabutin—Abdominal pain—Erlotinib—kidney cancer	0.000309	0.00105	CcSEcCtD
Rifabutin—Body temperature increased—Erlotinib—kidney cancer	0.000309	0.00105	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000308	0.00105	CcSEcCtD
Rifabutin—Anaemia—Gemcitabine—kidney cancer	0.000307	0.00105	CcSEcCtD
Rifabutin—Neutropenia—Capecitabine—kidney cancer	0.000307	0.00104	CcSEcCtD
Rifabutin—Insomnia—Sunitinib—kidney cancer	0.000306	0.00104	CcSEcCtD
Rifabutin—Decreased appetite—Sorafenib—kidney cancer	0.000306	0.00104	CcSEcCtD
Rifabutin—Anorexia—Dactinomycin—kidney cancer	0.000305	0.00104	CcSEcCtD
Rifabutin—Nausea—Pazopanib—kidney cancer	0.000305	0.00104	CcSEcCtD
Rifabutin—Paraesthesia—Sunitinib—kidney cancer	0.000304	0.00103	CcSEcCtD
Rifabutin—Convulsion—Vincristine—kidney cancer	0.000304	0.00103	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000304	0.00103	CcSEcCtD
Rifabutin—Dyspnoea—Sunitinib—kidney cancer	0.000302	0.00103	CcSEcCtD
Rifabutin—Pain—Sorafenib—kidney cancer	0.000301	0.00102	CcSEcCtD
Rifabutin—Hypersensitivity—Vinblastine—kidney cancer	0.0003	0.00102	CcSEcCtD
Rifabutin—Eye disorder—Paclitaxel—kidney cancer	0.000299	0.00102	CcSEcCtD
Rifabutin—Myalgia—Vincristine—kidney cancer	0.000299	0.00102	CcSEcCtD
Rifabutin—Hypersensitivity—Everolimus—kidney cancer	0.000298	0.00101	CcSEcCtD
Rifabutin—Dyspepsia—Sunitinib—kidney cancer	0.000298	0.00101	CcSEcCtD
Rifabutin—Leukopenia—Gemcitabine—kidney cancer	0.000298	0.00101	CcSEcCtD
Rifabutin—Decreased appetite—Sunitinib—kidney cancer	0.000294	0.001	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000292	0.000993	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000292	0.000992	CcSEcCtD
Rifabutin—Asthenia—Vinblastine—kidney cancer	0.000292	0.000992	CcSEcCtD
Rifabutin—Asthenia—Everolimus—kidney cancer	0.000291	0.000988	CcSEcCtD
Rifabutin—Pain—Sunitinib—kidney cancer	0.000289	0.000984	CcSEcCtD
Rifabutin—Immune system disorder—Paclitaxel—kidney cancer	0.000289	0.000983	CcSEcCtD
Rifabutin—Gastrointestinal pain—Sorafenib—kidney cancer	0.000288	0.000978	CcSEcCtD
Rifabutin—Pruritus—Everolimus—kidney cancer	0.000287	0.000975	CcSEcCtD
Rifabutin—Jaundice—Capecitabine—kidney cancer	0.000285	0.00097	CcSEcCtD
Rifabutin—Chest pain—Gemcitabine—kidney cancer	0.000283	0.000963	CcSEcCtD
Rifabutin—Arthralgia—Gemcitabine—kidney cancer	0.000283	0.000963	CcSEcCtD
Rifabutin—Myalgia—Gemcitabine—kidney cancer	0.000283	0.000963	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.000281	0.000957	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000281	0.000956	CcSEcCtD
Rifabutin—Asthenia—Erlotinib—kidney cancer	0.00028	0.000954	CcSEcCtD
Rifabutin—Thrombocytopenia—Vincristine—kidney cancer	0.00028	0.000953	CcSEcCtD
Rifabutin—Decreased appetite—Dactinomycin—kidney cancer	0.000278	0.000947	CcSEcCtD
Rifabutin—Diarrhoea—Vinblastine—kidney cancer	0.000278	0.000946	CcSEcCtD
Rifabutin—Abdominal pain—Sorafenib—kidney cancer	0.000278	0.000945	CcSEcCtD
Rifabutin—Body temperature increased—Sorafenib—kidney cancer	0.000278	0.000945	CcSEcCtD
Rifabutin—Diarrhoea—Everolimus—kidney cancer	0.000277	0.000943	CcSEcCtD
Rifabutin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000277	0.000941	CcSEcCtD
Rifabutin—Hepatobiliary disease—Capecitabine—kidney cancer	0.000277	0.000941	CcSEcCtD
Rifabutin—Pruritus—Erlotinib—kidney cancer	0.000277	0.00094	CcSEcCtD
Rifabutin—Flatulence—Paclitaxel—kidney cancer	0.000274	0.000933	CcSEcCtD
Rifabutin—Pain—Dactinomycin—kidney cancer	0.000274	0.000932	CcSEcCtD
Rifabutin—Agranulocytosis—Capecitabine—kidney cancer	0.000273	0.000928	CcSEcCtD
Rifabutin—Anorexia—Vincristine—kidney cancer	0.000273	0.000928	CcSEcCtD
Rifabutin—Dysgeusia—Paclitaxel—kidney cancer	0.000273	0.000928	CcSEcCtD
Rifabutin—Abdominal pain—Sunitinib—kidney cancer	0.000267	0.00091	CcSEcCtD
Rifabutin—Body temperature increased—Sunitinib—kidney cancer	0.000267	0.00091	CcSEcCtD
Rifabutin—Diarrhoea—Erlotinib—kidney cancer	0.000267	0.000909	CcSEcCtD
Rifabutin—Thrombocytopenia—Gemcitabine—kidney cancer	0.000266	0.000904	CcSEcCtD
Rifabutin—Feeling abnormal—Dactinomycin—kidney cancer	0.000264	0.000898	CcSEcCtD
Rifabutin—Skin disorder—Gemcitabine—kidney cancer	0.000264	0.000897	CcSEcCtD
Rifabutin—Hepatitis—Capecitabine—kidney cancer	0.000263	0.000893	CcSEcCtD
Rifabutin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000262	0.000891	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000261	0.000887	CcSEcCtD
Rifabutin—Hypersensitivity—Sorafenib—kidney cancer	0.000259	0.000881	CcSEcCtD
Rifabutin—Insomnia—Vincristine—kidney cancer	0.000259	0.00088	CcSEcCtD
Rifabutin—Anorexia—Gemcitabine—kidney cancer	0.000259	0.00088	CcSEcCtD
Rifabutin—Vomiting—Vinblastine—kidney cancer	0.000259	0.000879	CcSEcCtD
Rifabutin—Connective tissue disorder—Capecitabine—kidney cancer	0.000258	0.000877	CcSEcCtD
Rifabutin—Vomiting—Everolimus—kidney cancer	0.000258	0.000876	CcSEcCtD
Rifabutin—Anaemia—Paclitaxel—kidney cancer	0.000257	0.000875	CcSEcCtD
Rifabutin—Paraesthesia—Vincristine—kidney cancer	0.000257	0.000874	CcSEcCtD
Rifabutin—Rash—Everolimus—kidney cancer	0.000255	0.000869	CcSEcCtD
Rifabutin—Dermatitis—Everolimus—kidney cancer	0.000255	0.000868	CcSEcCtD
Rifabutin—Headache—Vinblastine—kidney cancer	0.000255	0.000866	CcSEcCtD
Rifabutin—Headache—Everolimus—kidney cancer	0.000254	0.000863	CcSEcCtD
Rifabutin—Abdominal pain—Dactinomycin—kidney cancer	0.000253	0.000861	CcSEcCtD
Rifabutin—Body temperature increased—Dactinomycin—kidney cancer	0.000253	0.000861	CcSEcCtD
Rifabutin—Asthenia—Sorafenib—kidney cancer	0.000252	0.000858	CcSEcCtD
Rifabutin—Leukopenia—Paclitaxel—kidney cancer	0.000249	0.000848	CcSEcCtD
Rifabutin—Hypersensitivity—Sunitinib—kidney cancer	0.000249	0.000848	CcSEcCtD
Rifabutin—Decreased appetite—Vincristine—kidney cancer	0.000249	0.000846	CcSEcCtD
Rifabutin—Pruritus—Sorafenib—kidney cancer	0.000249	0.000846	CcSEcCtD
Rifabutin—Vomiting—Erlotinib—kidney cancer	0.000249	0.000845	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000247	0.000841	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000247	0.00084	CcSEcCtD
Rifabutin—Rash—Erlotinib—kidney cancer	0.000246	0.000838	CcSEcCtD
Rifabutin—Dermatitis—Erlotinib—kidney cancer	0.000246	0.000837	CcSEcCtD
Rifabutin—Insomnia—Gemcitabine—kidney cancer	0.000246	0.000835	CcSEcCtD
Rifabutin—Eye disorder—Capecitabine—kidney cancer	0.000245	0.000834	CcSEcCtD
Rifabutin—Headache—Erlotinib—kidney cancer	0.000245	0.000833	CcSEcCtD
Rifabutin—Pain—Vincristine—kidney cancer	0.000245	0.000832	CcSEcCtD
Rifabutin—Paraesthesia—Gemcitabine—kidney cancer	0.000244	0.000829	CcSEcCtD
Rifabutin—Asthenia—Sunitinib—kidney cancer	0.000243	0.000826	CcSEcCtD
Rifabutin—Dyspnoea—Gemcitabine—kidney cancer	0.000242	0.000823	CcSEcCtD
Rifabutin—Nausea—Vinblastine—kidney cancer	0.000242	0.000821	CcSEcCtD
Rifabutin—Convulsion—Paclitaxel—kidney cancer	0.000241	0.000821	CcSEcCtD
Rifabutin—Nausea—Everolimus—kidney cancer	0.000241	0.000818	CcSEcCtD
Rifabutin—Diarrhoea—Sorafenib—kidney cancer	0.000241	0.000818	CcSEcCtD
Rifabutin—Pruritus—Sunitinib—kidney cancer	0.000239	0.000814	CcSEcCtD
Rifabutin—Immune system disorder—Capecitabine—kidney cancer	0.000237	0.000807	CcSEcCtD
Rifabutin—Chest pain—Paclitaxel—kidney cancer	0.000237	0.000806	CcSEcCtD
Rifabutin—Arthralgia—Paclitaxel—kidney cancer	0.000237	0.000806	CcSEcCtD
Rifabutin—Myalgia—Paclitaxel—kidney cancer	0.000237	0.000806	CcSEcCtD
Rifabutin—Decreased appetite—Gemcitabine—kidney cancer	0.000236	0.000803	CcSEcCtD
Rifabutin—Hypersensitivity—Dactinomycin—kidney cancer	0.000236	0.000803	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000235	0.000801	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000234	0.000797	CcSEcCtD
Rifabutin—Gastrointestinal pain—Vincristine—kidney cancer	0.000234	0.000796	CcSEcCtD
Rifabutin—Pain—Gemcitabine—kidney cancer	0.000232	0.00079	CcSEcCtD
Rifabutin—Nausea—Erlotinib—kidney cancer	0.000232	0.00079	CcSEcCtD
Rifabutin—Diarrhoea—Sunitinib—kidney cancer	0.000231	0.000787	CcSEcCtD
Rifabutin—Asthenia—Dactinomycin—kidney cancer	0.00023	0.000782	CcSEcCtD
Rifabutin—Confusional state—Paclitaxel—kidney cancer	0.000229	0.000779	CcSEcCtD
Rifabutin—Body temperature increased—Vincristine—kidney cancer	0.000226	0.000769	CcSEcCtD
Rifabutin—Abdominal pain—Vincristine—kidney cancer	0.000226	0.000769	CcSEcCtD
Rifabutin—Flatulence—Capecitabine—kidney cancer	0.000225	0.000766	CcSEcCtD
Rifabutin—Dysgeusia—Capecitabine—kidney cancer	0.000224	0.000761	CcSEcCtD
Rifabutin—Feeling abnormal—Gemcitabine—kidney cancer	0.000224	0.000761	CcSEcCtD
Rifabutin—Shock—Paclitaxel—kidney cancer	0.000224	0.000761	CcSEcCtD
Rifabutin—Vomiting—Sorafenib—kidney cancer	0.000224	0.00076	CcSEcCtD
Rifabutin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000223	0.000757	CcSEcCtD
Rifabutin—Rash—Sorafenib—kidney cancer	0.000222	0.000754	CcSEcCtD
Rifabutin—Dermatitis—Sorafenib—kidney cancer	0.000221	0.000753	CcSEcCtD
Rifabutin—Skin disorder—Paclitaxel—kidney cancer	0.000221	0.000751	CcSEcCtD
Rifabutin—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.00022	0.000749	CcSEcCtD
Rifabutin—Headache—Sorafenib—kidney cancer	0.00022	0.000749	CcSEcCtD
Rifabutin—Diarrhoea—Dactinomycin—kidney cancer	0.000219	0.000745	CcSEcCtD
Rifabutin—Anorexia—Paclitaxel—kidney cancer	0.000217	0.000737	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000216	0.000734	CcSEcCtD
Rifabutin—Vomiting—Sunitinib—kidney cancer	0.000215	0.000732	CcSEcCtD
Rifabutin—Body temperature increased—Gemcitabine—kidney cancer	0.000215	0.00073	CcSEcCtD
Rifabutin—Rash—Sunitinib—kidney cancer	0.000213	0.000726	CcSEcCtD
Rifabutin—Dermatitis—Sunitinib—kidney cancer	0.000213	0.000725	CcSEcCtD
Rifabutin—Headache—Sunitinib—kidney cancer	0.000212	0.000721	CcSEcCtD
Rifabutin—Anaemia—Capecitabine—kidney cancer	0.000211	0.000718	CcSEcCtD
Rifabutin—Hypersensitivity—Vincristine—kidney cancer	0.000211	0.000717	CcSEcCtD
Rifabutin—Eosinophilia—Doxorubicin—kidney cancer	0.000209	0.000712	CcSEcCtD
Rifabutin—Nausea—Sorafenib—kidney cancer	0.000209	0.00071	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000207	0.000704	CcSEcCtD
Rifabutin—Insomnia—Paclitaxel—kidney cancer	0.000206	0.000699	CcSEcCtD
Rifabutin—Asthenia—Vincristine—kidney cancer	0.000205	0.000698	CcSEcCtD
Rifabutin—Leukopenia—Capecitabine—kidney cancer	0.000205	0.000696	CcSEcCtD
Rifabutin—Paraesthesia—Paclitaxel—kidney cancer	0.000204	0.000694	CcSEcCtD
Rifabutin—Vomiting—Dactinomycin—kidney cancer	0.000204	0.000693	CcSEcCtD
Rifabutin—Dyspnoea—Paclitaxel—kidney cancer	0.000203	0.000689	CcSEcCtD
Rifabutin—Rash—Dactinomycin—kidney cancer	0.000202	0.000687	CcSEcCtD
Rifabutin—Nausea—Sunitinib—kidney cancer	0.000201	0.000683	CcSEcCtD
Rifabutin—Pancytopenia—Doxorubicin—kidney cancer	0.000201	0.000683	CcSEcCtD
Rifabutin—Dyspepsia—Paclitaxel—kidney cancer	0.0002	0.00068	CcSEcCtD
Rifabutin—Neutropenia—Doxorubicin—kidney cancer	0.000198	0.000672	CcSEcCtD
Rifabutin—Decreased appetite—Paclitaxel—kidney cancer	0.000198	0.000672	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000196	0.000667	CcSEcCtD
Rifabutin—Diarrhoea—Vincristine—kidney cancer	0.000196	0.000666	CcSEcCtD
Rifabutin—Asthenia—Gemcitabine—kidney cancer	0.000195	0.000662	CcSEcCtD
Rifabutin—Arthralgia—Capecitabine—kidney cancer	0.000195	0.000662	CcSEcCtD
Rifabutin—Chest pain—Capecitabine—kidney cancer	0.000195	0.000662	CcSEcCtD
Rifabutin—Myalgia—Capecitabine—kidney cancer	0.000195	0.000662	CcSEcCtD
Rifabutin—Pain—Paclitaxel—kidney cancer	0.000194	0.000661	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000193	0.000657	CcSEcCtD
Rifabutin—Pruritus—Gemcitabine—kidney cancer	0.000192	0.000653	CcSEcCtD
Rifabutin—Nausea—Dactinomycin—kidney cancer	0.00019	0.000647	CcSEcCtD
Rifabutin—Confusional state—Capecitabine—kidney cancer	0.000188	0.00064	CcSEcCtD
Rifabutin—Feeling abnormal—Paclitaxel—kidney cancer	0.000187	0.000637	CcSEcCtD
Rifabutin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000186	0.000632	CcSEcCtD
Rifabutin—Diarrhoea—Gemcitabine—kidney cancer	0.000186	0.000632	CcSEcCtD
Rifabutin—Jaundice—Doxorubicin—kidney cancer	0.000184	0.000625	CcSEcCtD
Rifabutin—Shock—Capecitabine—kidney cancer	0.000184	0.000624	CcSEcCtD
Rifabutin—Thrombocytopenia—Capecitabine—kidney cancer	0.000183	0.000621	CcSEcCtD
Rifabutin—Vomiting—Vincristine—kidney cancer	0.000182	0.000619	CcSEcCtD
Rifabutin—Skin disorder—Capecitabine—kidney cancer	0.000181	0.000616	CcSEcCtD
Rifabutin—Rash—Vincristine—kidney cancer	0.00018	0.000614	CcSEcCtD
Rifabutin—Dermatitis—Vincristine—kidney cancer	0.00018	0.000613	CcSEcCtD
Rifabutin—Body temperature increased—Paclitaxel—kidney cancer	0.00018	0.000611	CcSEcCtD
Rifabutin—Abdominal pain—Paclitaxel—kidney cancer	0.00018	0.000611	CcSEcCtD
Rifabutin—Headache—Vincristine—kidney cancer	0.000179	0.00061	CcSEcCtD
Rifabutin—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000178	0.000606	CcSEcCtD
Rifabutin—Anorexia—Capecitabine—kidney cancer	0.000178	0.000605	CcSEcCtD
Rifabutin—Agranulocytosis—Doxorubicin—kidney cancer	0.000176	0.000598	CcSEcCtD
Rifabutin—Vomiting—Gemcitabine—kidney cancer	0.000173	0.000587	CcSEcCtD
Rifabutin—Rash—Gemcitabine—kidney cancer	0.000171	0.000582	CcSEcCtD
Rifabutin—Dermatitis—Gemcitabine—kidney cancer	0.000171	0.000582	CcSEcCtD
Rifabutin—Headache—Gemcitabine—kidney cancer	0.00017	0.000578	CcSEcCtD
Rifabutin—Nausea—Vincristine—kidney cancer	0.00017	0.000578	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00017	0.000578	CcSEcCtD
Rifabutin—Hepatitis—Doxorubicin—kidney cancer	0.000169	0.000576	CcSEcCtD
Rifabutin—Insomnia—Capecitabine—kidney cancer	0.000169	0.000574	CcSEcCtD
Rifabutin—Paraesthesia—Capecitabine—kidney cancer	0.000167	0.00057	CcSEcCtD
Rifabutin—Hypersensitivity—Paclitaxel—kidney cancer	0.000167	0.00057	CcSEcCtD
Rifabutin—Connective tissue disorder—Doxorubicin—kidney cancer	0.000166	0.000566	CcSEcCtD
Rifabutin—Dyspnoea—Capecitabine—kidney cancer	0.000166	0.000566	CcSEcCtD
Rifabutin—Dyspepsia—Capecitabine—kidney cancer	0.000164	0.000558	CcSEcCtD
Rifabutin—Asthenia—Paclitaxel—kidney cancer	0.000163	0.000555	CcSEcCtD
Rifabutin—Decreased appetite—Capecitabine—kidney cancer	0.000162	0.000551	CcSEcCtD
Rifabutin—Nausea—Gemcitabine—kidney cancer	0.000161	0.000548	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000161	0.000548	CcSEcCtD
Rifabutin—Pruritus—Paclitaxel—kidney cancer	0.000161	0.000547	CcSEcCtD
Rifabutin—Pain—Capecitabine—kidney cancer	0.00016	0.000542	CcSEcCtD
Rifabutin—Eye disorder—Doxorubicin—kidney cancer	0.000158	0.000538	CcSEcCtD
Rifabutin—Diarrhoea—Paclitaxel—kidney cancer	0.000156	0.000529	CcSEcCtD
Rifabutin—Feeling abnormal—Capecitabine—kidney cancer	0.000154	0.000523	CcSEcCtD
Rifabutin—Immune system disorder—Doxorubicin—kidney cancer	0.000153	0.00052	CcSEcCtD
Rifabutin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000153	0.000519	CcSEcCtD
Rifabutin—Abdominal pain—Capecitabine—kidney cancer	0.000147	0.000501	CcSEcCtD
Rifabutin—Body temperature increased—Capecitabine—kidney cancer	0.000147	0.000501	CcSEcCtD
Rifabutin—Flatulence—Doxorubicin—kidney cancer	0.000145	0.000494	CcSEcCtD
Rifabutin—Vomiting—Paclitaxel—kidney cancer	0.000145	0.000491	CcSEcCtD
Rifabutin—Dysgeusia—Doxorubicin—kidney cancer	0.000144	0.000491	CcSEcCtD
Rifabutin—Rash—Paclitaxel—kidney cancer	0.000143	0.000487	CcSEcCtD
Rifabutin—Dermatitis—Paclitaxel—kidney cancer	0.000143	0.000487	CcSEcCtD
Rifabutin—Headache—Paclitaxel—kidney cancer	0.000142	0.000484	CcSEcCtD
Rifabutin—Hypersensitivity—Capecitabine—kidney cancer	0.000137	0.000467	CcSEcCtD
Rifabutin—Anaemia—Doxorubicin—kidney cancer	0.000136	0.000463	CcSEcCtD
Rifabutin—Nausea—Paclitaxel—kidney cancer	0.000135	0.000459	CcSEcCtD
Rifabutin—Asthenia—Capecitabine—kidney cancer	0.000134	0.000455	CcSEcCtD
Rifabutin—Pruritus—Capecitabine—kidney cancer	0.000132	0.000449	CcSEcCtD
Rifabutin—Leukopenia—Doxorubicin—kidney cancer	0.000132	0.000448	CcSEcCtD
Rifabutin—Convulsion—Doxorubicin—kidney cancer	0.000128	0.000434	CcSEcCtD
Rifabutin—Diarrhoea—Capecitabine—kidney cancer	0.000128	0.000434	CcSEcCtD
Rifabutin—Chest pain—Doxorubicin—kidney cancer	0.000125	0.000427	CcSEcCtD
Rifabutin—Arthralgia—Doxorubicin—kidney cancer	0.000125	0.000427	CcSEcCtD
Rifabutin—Myalgia—Doxorubicin—kidney cancer	0.000125	0.000427	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000125	0.000424	CcSEcCtD
Rifabutin—Confusional state—Doxorubicin—kidney cancer	0.000121	0.000412	CcSEcCtD
Rifabutin—Vomiting—Capecitabine—kidney cancer	0.000119	0.000403	CcSEcCtD
Rifabutin—Shock—Doxorubicin—kidney cancer	0.000118	0.000402	CcSEcCtD
Rifabutin—Thrombocytopenia—Doxorubicin—kidney cancer	0.000118	0.0004	CcSEcCtD
Rifabutin—Rash—Capecitabine—kidney cancer	0.000118	0.0004	CcSEcCtD
Rifabutin—Dermatitis—Capecitabine—kidney cancer	0.000118	0.0004	CcSEcCtD
Rifabutin—Headache—Capecitabine—kidney cancer	0.000117	0.000397	CcSEcCtD
Rifabutin—Skin disorder—Doxorubicin—kidney cancer	0.000117	0.000397	CcSEcCtD
Rifabutin—Anorexia—Doxorubicin—kidney cancer	0.000115	0.00039	CcSEcCtD
Rifabutin—Nausea—Capecitabine—kidney cancer	0.000111	0.000377	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.00011	0.000373	CcSEcCtD
Rifabutin—Insomnia—Doxorubicin—kidney cancer	0.000109	0.00037	CcSEcCtD
Rifabutin—Paraesthesia—Doxorubicin—kidney cancer	0.000108	0.000367	CcSEcCtD
Rifabutin—Dyspnoea—Doxorubicin—kidney cancer	0.000107	0.000365	CcSEcCtD
Rifabutin—Dyspepsia—Doxorubicin—kidney cancer	0.000106	0.00036	CcSEcCtD
Rifabutin—Decreased appetite—Doxorubicin—kidney cancer	0.000105	0.000355	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000104	0.000353	CcSEcCtD
Rifabutin—Pain—Doxorubicin—kidney cancer	0.000103	0.00035	CcSEcCtD
Rifabutin—Feeling abnormal—Doxorubicin—kidney cancer	9.91e-05	0.000337	CcSEcCtD
Rifabutin—Gastrointestinal pain—Doxorubicin—kidney cancer	9.83e-05	0.000334	CcSEcCtD
Rifabutin—Body temperature increased—Doxorubicin—kidney cancer	9.5e-05	0.000323	CcSEcCtD
Rifabutin—Abdominal pain—Doxorubicin—kidney cancer	9.5e-05	0.000323	CcSEcCtD
Rifabutin—Hypersensitivity—Doxorubicin—kidney cancer	8.86e-05	0.000301	CcSEcCtD
Rifabutin—Asthenia—Doxorubicin—kidney cancer	8.63e-05	0.000293	CcSEcCtD
Rifabutin—Pruritus—Doxorubicin—kidney cancer	8.51e-05	0.000289	CcSEcCtD
Rifabutin—Diarrhoea—Doxorubicin—kidney cancer	8.23e-05	0.00028	CcSEcCtD
Rifabutin—Vomiting—Doxorubicin—kidney cancer	7.64e-05	0.00026	CcSEcCtD
Rifabutin—Rash—Doxorubicin—kidney cancer	7.58e-05	0.000258	CcSEcCtD
Rifabutin—Dermatitis—Doxorubicin—kidney cancer	7.57e-05	0.000258	CcSEcCtD
Rifabutin—Headache—Doxorubicin—kidney cancer	7.53e-05	0.000256	CcSEcCtD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	7.42e-05	0.000359	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—AKAP13—kidney cancer	7.42e-05	0.000359	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CASP2—kidney cancer	7.42e-05	0.000359	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—JUN—kidney cancer	7.38e-05	0.000357	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PAK1—kidney cancer	7.34e-05	0.000355	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—CTNNB1—kidney cancer	7.32e-05	0.000354	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—MAPK1—kidney cancer	7.27e-05	0.000352	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KIT—kidney cancer	7.22e-05	0.00035	CbGpPWpGaD
Rifabutin—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	7.17e-05	0.000347	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNA1—kidney cancer	7.16e-05	0.000347	CbGpPWpGaD
Rifabutin—Nausea—Doxorubicin—kidney cancer	7.14e-05	0.000243	CcSEcCtD
Rifabutin—HSP90B1—Immune System—PTEN—kidney cancer	7.13e-05	0.000345	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	6.99e-05	0.000338	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ACHE—kidney cancer	6.88e-05	0.000333	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTT1—kidney cancer	6.88e-05	0.000333	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—kidney cancer	6.88e-05	0.000333	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	6.87e-05	0.000333	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—EGR1—kidney cancer	6.86e-05	0.000332	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—VEGFA—kidney cancer	6.85e-05	0.000332	CbGpPWpGaD
Rifabutin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.83e-05	0.00033	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—SLC2A1—kidney cancer	6.82e-05	0.00033	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—GRB7—kidney cancer	6.78e-05	0.000328	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—JUNB—kidney cancer	6.77e-05	0.000328	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IFNA2—kidney cancer	6.66e-05	0.000323	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTT1—kidney cancer	6.53e-05	0.000316	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—SCARB1—kidney cancer	6.51e-05	0.000315	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MAPK3—kidney cancer	6.48e-05	0.000314	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS1—kidney cancer	6.44e-05	0.000312	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—RAF1—kidney cancer	6.42e-05	0.000311	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—RELA—kidney cancer	6.39e-05	0.000309	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—ERBB2—kidney cancer	6.35e-05	0.000307	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	6.32e-05	0.000306	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PSMD7—kidney cancer	6.32e-05	0.000306	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ITPR2—kidney cancer	6.31e-05	0.000305	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	6.19e-05	0.000299	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—MAPK1—kidney cancer	6.17e-05	0.000299	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN2A—kidney cancer	6.15e-05	0.000298	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—PTGS1—kidney cancer	6.12e-05	0.000296	CbGpPWpGaD
Rifabutin—HSP90AA1—Cellular responses to stress—TP53—kidney cancer	6.1e-05	0.000295	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—MAPK3—kidney cancer	6.1e-05	0.000295	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CDKN1B—kidney cancer	6.09e-05	0.000295	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—BCHE—kidney cancer	5.99e-05	0.00029	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—SLC5A5—kidney cancer	5.92e-05	0.000286	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTP1—kidney cancer	5.86e-05	0.000284	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	5.84e-05	0.000283	CbGpPWpGaD
Rifabutin—HSP90AA1—Axon guidance—KRAS—kidney cancer	5.83e-05	0.000282	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—CCND1—kidney cancer	5.81e-05	0.000281	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—MAPK1—kidney cancer	5.8e-05	0.000281	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	5.78e-05	0.00028	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CTNNA1—kidney cancer	5.72e-05	0.000277	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—SLC2A1—kidney cancer	5.72e-05	0.000277	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HSPB1—kidney cancer	5.68e-05	0.000275	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—EIF4EBP1—kidney cancer	5.68e-05	0.000275	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—RAF1—kidney cancer	5.67e-05	0.000274	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—RELA—kidney cancer	5.64e-05	0.000273	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—ERBB2—kidney cancer	5.61e-05	0.000271	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD8A—kidney cancer	5.6e-05	0.000271	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—CTNNB1—kidney cancer	5.56e-05	0.000269	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MTOR—kidney cancer	5.53e-05	0.000268	CbGpPWpGaD
Rifabutin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.53e-05	0.000268	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CD4—kidney cancer	5.52e-05	0.000267	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN2B—kidney cancer	5.51e-05	0.000267	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—KRAS—kidney cancer	5.48e-05	0.000265	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CDKN1B—kidney cancer	5.44e-05	0.000264	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—GSTM1—kidney cancer	5.39e-05	0.000261	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	5.31e-05	0.000257	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TSC1—kidney cancer	5.28e-05	0.000256	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PSMD7—kidney cancer	5.28e-05	0.000256	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ANXA1—kidney cancer	5.28e-05	0.000256	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—CCND1—kidney cancer	5.19e-05	0.000251	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CDKN1B—kidney cancer	5.19e-05	0.000251	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—FLT1—kidney cancer	5.12e-05	0.000248	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	5.11e-05	0.000247	CbGpPWpGaD
Rifabutin—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	5.04e-05	0.000244	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—PIK3CA—kidney cancer	5.03e-05	0.000244	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—JUN—kidney cancer	4.94e-05	0.000239	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—CTNNB1—kidney cancer	4.91e-05	0.000238	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—VEGFA—kidney cancer	4.89e-05	0.000237	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MAPK3—kidney cancer	4.79e-05	0.000232	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PTEN—kidney cancer	4.78e-05	0.000231	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTP1—kidney cancer	4.77e-05	0.000231	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—TSC2—kidney cancer	4.76e-05	0.000231	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JUNB—kidney cancer	4.74e-05	0.00023	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PAK1—kidney cancer	4.74e-05	0.00023	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MYC—kidney cancer	4.66e-05	0.000226	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MAPK3—kidney cancer	4.63e-05	0.000224	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle, Mitotic—MAPK1—kidney cancer	4.56e-05	0.000221	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTP1—kidney cancer	4.52e-05	0.000219	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—ABCB1—kidney cancer	4.51e-05	0.000218	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ACY1—kidney cancer	4.49e-05	0.000217	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	4.46e-05	0.000216	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—HIF1A—kidney cancer	4.41e-05	0.000213	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—MAPK1—kidney cancer	4.4e-05	0.000213	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—TSC2—kidney cancer	4.4e-05	0.000213	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—GSTM1—kidney cancer	4.38e-05	0.000212	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MAPK3—kidney cancer	4.28e-05	0.000207	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KIT—kidney cancer	4.21e-05	0.000204	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MYC—kidney cancer	4.17e-05	0.000202	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—GSTM1—kidney cancer	4.16e-05	0.000201	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—KRAS—kidney cancer	4.16e-05	0.000201	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—CYP1A1—kidney cancer	4.15e-05	0.000201	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	4.1e-05	0.000199	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK3—kidney cancer	4.09e-05	0.000198	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—MAPK1—kidney cancer	4.08e-05	0.000197	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.94e-05	0.000191	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—MAPK1—kidney cancer	3.89e-05	0.000188	CbGpPWpGaD
Rifabutin—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.89e-05	0.000188	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KIT—kidney cancer	3.88e-05	0.000188	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—APC—kidney cancer	3.88e-05	0.000188	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF2—kidney cancer	3.88e-05	0.000188	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDH1—kidney cancer	3.87e-05	0.000187	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN2B—kidney cancer	3.86e-05	0.000187	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.83e-05	0.000185	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PDHB—kidney cancer	3.82e-05	0.000185	CbGpPWpGaD
Rifabutin—CYP1A2—Biological oxidations—POMC—kidney cancer	3.81e-05	0.000184	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IGF1R—kidney cancer	3.75e-05	0.000182	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—KRAS—kidney cancer	3.67e-05	0.000178	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—BRAF—kidney cancer	3.65e-05	0.000177	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CCBL1—kidney cancer	3.59e-05	0.000174	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ACY1—kidney cancer	3.47e-05	0.000168	CbGpPWpGaD
Rifabutin—HSP90AA1—Cell Cycle—TP53—kidney cancer	3.42e-05	0.000166	CbGpPWpGaD
Rifabutin—HSP90AA1—Innate Immune System—PIK3CA—kidney cancer	3.37e-05	0.000163	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—RAF1—kidney cancer	3.3e-05	0.00016	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—RELA—kidney cancer	3.29e-05	0.000159	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—ERBB2—kidney cancer	3.27e-05	0.000158	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.25e-05	0.000157	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MTOR—kidney cancer	3.22e-05	0.000156	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CD4—kidney cancer	3.22e-05	0.000156	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GLIPR1—kidney cancer	3.11e-05	0.000151	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PPAT—kidney cancer	3.11e-05	0.000151	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—POMC—kidney cancer	3.1e-05	0.00015	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—HIF1A—kidney cancer	3.09e-05	0.000149	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TSC2—kidney cancer	3.08e-05	0.000149	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.07e-05	0.000149	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—RAF1—kidney cancer	3.05e-05	0.000148	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.04e-05	0.000147	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CDKN1B—kidney cancer	3.03e-05	0.000146	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—ERBB2—kidney cancer	3.02e-05	0.000146	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MTOR—kidney cancer	2.98e-05	0.000144	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CD4—kidney cancer	2.97e-05	0.000144	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—IL2—kidney cancer	2.96e-05	0.000143	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KDR—kidney cancer	2.95e-05	0.000143	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTGS2—kidney cancer	2.95e-05	0.000143	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PDHB—kidney cancer	2.95e-05	0.000143	CbGpPWpGaD
Rifabutin—CYP3A4—Biological oxidations—POMC—kidney cancer	2.94e-05	0.000142	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—APRT—kidney cancer	2.9e-05	0.00014	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—FH—kidney cancer	2.9e-05	0.00014	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—JUN—kidney cancer	2.88e-05	0.000139	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CTNNB1—kidney cancer	2.86e-05	0.000138	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.83e-05	0.000137	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CDKN1B—kidney cancer	2.79e-05	0.000135	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PTEN—kidney cancer	2.79e-05	0.000135	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CCBL1—kidney cancer	2.77e-05	0.000134	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GPC3—kidney cancer	2.72e-05	0.000132	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—APC—kidney cancer	2.72e-05	0.000132	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KIT—kidney cancer	2.72e-05	0.000132	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA2—kidney cancer	2.65e-05	0.000128	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—CTNNB1—kidney cancer	2.64e-05	0.000128	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—POMC—kidney cancer	2.59e-05	0.000125	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALAD—kidney cancer	2.58e-05	0.000125	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PTEN—kidney cancer	2.57e-05	0.000124	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—BRAF—kidney cancer	2.56e-05	0.000124	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ST3GAL2—kidney cancer	2.52e-05	0.000122	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTGS2—kidney cancer	2.47e-05	0.00012	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ALDH1A1—kidney cancer	2.46e-05	0.000119	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.4e-05	0.000116	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PPAT—kidney cancer	2.4e-05	0.000116	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK3—kidney cancer	2.38e-05	0.000115	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PGK1—kidney cancer	2.36e-05	0.000114	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.36e-05	0.000114	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—LDHB—kidney cancer	2.31e-05	0.000112	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—MAPK1—kidney cancer	2.26e-05	0.00011	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—FH—kidney cancer	2.23e-05	0.000108	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—APRT—kidney cancer	2.23e-05	0.000108	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK3—kidney cancer	2.2e-05	0.000106	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PTEN—kidney cancer	2.15e-05	0.000104	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—KRAS—kidney cancer	2.14e-05	0.000104	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MYC—kidney cancer	2.14e-05	0.000103	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RAF1—kidney cancer	2.13e-05	0.000103	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—RELA—kidney cancer	2.13e-05	0.000103	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—ERBB2—kidney cancer	2.11e-05	0.000102	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GPC3—kidney cancer	2.1e-05	0.000102	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—MAPK1—kidney cancer	2.09e-05	0.000101	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MTOR—kidney cancer	2.08e-05	0.000101	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA2—kidney cancer	2.04e-05	9.89e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CA9—kidney cancer	2.01e-05	9.71e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALAD—kidney cancer	1.99e-05	9.64e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—KRAS—kidney cancer	1.97e-05	9.56e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—PIK3CA—kidney cancer	1.97e-05	9.51e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.96e-05	9.49e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CDKN1B—kidney cancer	1.96e-05	9.47e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.94e-05	9.41e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—IL2—kidney cancer	1.91e-05	9.26e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.9e-05	9.2e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CCND1—kidney cancer	1.87e-05	9.03e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—JUN—kidney cancer	1.86e-05	9.01e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—CTNNB1—kidney cancer	1.85e-05	8.94e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PGK1—kidney cancer	1.82e-05	8.82e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.82e-05	8.82e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—PIK3CA—kidney cancer	1.81e-05	8.78e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PTEN—kidney cancer	1.8e-05	8.72e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—LDHB—kidney cancer	1.79e-05	8.65e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CRABP1—kidney cancer	1.71e-05	8.26e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—VEGFA—kidney cancer	1.63e-05	7.87e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ITPR2—kidney cancer	1.59e-05	7.68e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CA9—kidney cancer	1.55e-05	7.5e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK3—kidney cancer	1.54e-05	7.45e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Metabolism—PIK3CA—kidney cancer	1.52e-05	7.35e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MYC—kidney cancer	1.5e-05	7.24e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—MAPK1—kidney cancer	1.46e-05	7.09e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.46e-05	7.08e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTT1—kidney cancer	1.45e-05	7e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ACHE—kidney cancer	1.45e-05	7e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—KRAS—kidney cancer	1.38e-05	6.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SCARB1—kidney cancer	1.37e-05	6.63e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS1—kidney cancer	1.36e-05	6.56e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PSMD7—kidney cancer	1.33e-05	6.43e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CRABP1—kidney cancer	1.32e-05	6.37e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—PIK3CA—kidney cancer	1.27e-05	6.15e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—BCHE—kidney cancer	1.26e-05	6.1e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.24e-05	6.03e-05	CbGpPWpGaD
Rifabutin—HSP90AA1—Signaling Pathways—TP53—kidney cancer	1.23e-05	5.95e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ITPR2—kidney cancer	1.22e-05	5.93e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.2e-05	5.82e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.17e-05	5.65e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ACHE—kidney cancer	1.12e-05	5.4e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTT1—kidney cancer	1.12e-05	5.4e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SCARB1—kidney cancer	1.06e-05	5.12e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS1—kidney cancer	1.05e-05	5.06e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PSMD7—kidney cancer	1.03e-05	4.97e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.02e-05	4.92e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTP1—kidney cancer	1e-05	4.85e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—BCHE—kidney cancer	9.73e-06	4.71e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC5A5—kidney cancer	9.61e-06	4.65e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—ABCB1—kidney cancer	9.49e-06	4.59e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—SLC2A1—kidney cancer	9.28e-06	4.49e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—GSTM1—kidney cancer	9.21e-06	4.46e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—CYP1A1—kidney cancer	8.73e-06	4.23e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTP1—kidney cancer	7.74e-06	3.75e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—ABCB1—kidney cancer	7.33e-06	3.55e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.18e-06	3.47e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—GSTM1—kidney cancer	7.11e-06	3.44e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—CYP1A1—kidney cancer	6.74e-06	3.26e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—POMC—kidney cancer	6.51e-06	3.15e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTGS2—kidney cancer	5.19e-06	2.51e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—POMC—kidney cancer	5.03e-06	2.43e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PTEN—kidney cancer	4.53e-06	2.19e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTGS2—kidney cancer	4.01e-06	1.94e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PTEN—kidney cancer	3.5e-06	1.69e-05	CbGpPWpGaD
Rifabutin—CYP1A2—Metabolism—PIK3CA—kidney cancer	3.2e-06	1.55e-05	CbGpPWpGaD
Rifabutin—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.47e-06	1.19e-05	CbGpPWpGaD
